Fundraising FoxMBX Capital — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
Contraline develops new contraceptive and reproductive health technologies, with a focus on male contraception.
BiotechDigital HealthMedical DevicesCharlottesville, US
Kevin Eisenfrats(Founder)inJohn Herr(Founder)
BoardIris Van Alderwerelt van Rosenburgh(Director)Martin J Emerson(Director)Tom Thorpe(Director)
Board seatGurdane Bhutani· per SEC Form D
Co-investorsBiotechnology Value FundAllied Venture PartnersAlumni VenturesAmboy Street VenturesAurum Venture PartnersBeni Venture Capital+19 more
Junction Health partners with Federally Qualified Health Centers (FQHCs) to set up and manage IV infusion therapy sites, expanding access to infusion services for chronically ill, uninsured, Medicaid, and underserved patients across the US.
Digital HealthHealthtechImpact & Social GoodMedical DevicesDenver, US
Ben Wiederholt(Co-founder & CEO)inVinny Polito(Co-founder & COO)inMatt Vestal(Co-founder & Chief Commercial Officer)in
BoardJason Hill(Director)
Board seatGurdane Bhutani· per SEC Form D
Keebler Health, founded in 2023, is a healthcare company focused on improving efficiency and efficacy in the healthcare industry.
AI & Machine LearningDigital HealthHealthtech
Isaac Park(CEO)inAndrew Stickney(COO)inKevin Hill(CTO)inTerrell Bacchus(CMO)in
Co-investorsFlare Capital PartnersHustle FundHypothesisNew Stack VenturesPrimordial VenturesTau Ventures+8 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.